Outi Salo-Ahen

Doctor of Science (Pharmacy); ScD (Pharm.)

Professor, Faculty of Science and Engineering, Pharmacy

https://orcid.org/0000-0003-0725-126X

Phone+358-469201190, +358-2-2154009
Emailouti.salo-ahen@abo.fi

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

24 Sep 2012 → 31 May 2015

PhD

… → 22 Feb 2006

Master

… → 20 Jun 2001

Bachelor

… → 4 May 1999

Fingerprint

Dive into the research topics where Outi Salo-Ahen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

952 Citations
15 h-Index
28 Article
5 Review Article or Literature Review
1 Commissioned report

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach
Usman Mirza, M., Saadabadi, A., Vanmeert, M., Salo-Ahen, O., Abdullah, I., Claes, S., De Jonghe, S., Schols, D., Ahmad, S. & Froeyen, M., 2020, In : European Journal of Pharmaceutical Sciences. p. –
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File

1 Citation (Scopus)
Hops compounds modulatory effects and 6-prenylnaringenin dual mode of action on GABAA receptors
Benkherouf, A. Y., Logrén, N., Somborac, T., Kortesniemi, M., Soini, S. L., Yang, B., Salo-Ahen, O., Laaksonen, O. & Uusi-Oukari, M., 2020, In : European Journal of Pharmacology. 873, p. –
Research output: Contribution to journal › Article › Scientific › peer-review

File

1 Citation (Scopus)
NBCZone: Universal three-dimensional construction of eleven amino acids near the catalytic nucleophile and base in the superfamily of (chymo)trypsin-like serine fold proteases
Denesyuk, A., Johnson, M. S., Salo-Ahen, O., Uversky, V. N. & Denessiouk, K., 2020, In : International Journal of Biological Macromolecules. 153, p. 399–411
Research output: Contribution to journal › Article › Scientific › peer-review

2 Citations (Scopus)
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro
Alamri, MA., ul Qamar M, T., Mirza, MU., Bhadane, R., Alqahtani, SM., Muneer, I., Froeyen, M. & Salo-Ahen, O., 2020, In : Journal of Biomolecular Structure and Dynamics. p. –
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
7 Citations (Scopus)
Inhibition of oncogenic kinases: an in vitro validated computational approach identified potential multi-target anticancer compounds
Ikram, N., Usman Mirza, M., Vanmeert, M., Froeyen, M., Salo-Ahen, O., Tahir, M., Qazi, A. & Ahmad, S., 2019, In : Biomolecules. 9, 4, p. –
Research output: Contribution to journal › Article › Scientific › peer-review

10 Citations (Scopus)

Education/Academic qualification

Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach

Hops compounds modulatory effects and 6-prenylnaringenin dual mode of action on GABAA receptors

NBCZone: Universal three-dimensional construction of eleven amino acids near the catalytic nucleophile and base in the superfamily of (chymo)trypsin-like serine fold proteases

Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro

Inhibition of oncogenic kinases: an in vitro validated computational approach identified potential multi-target anticancer compounds